Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells.
about
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionPim1 kinase synergizes with c-MYC to induce advanced prostate carcinomaNeuroendocrine differentiation in prostate cancerNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureCellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressorIonizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.ORTI: An Open-Access Repository of Transcriptional Interactions for Interrogating Mammalian Gene Expression Data.Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction.Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival.Autoantibody signature for the serologic detection of ovarian cancerReceptor-like protein-tyrosine phosphatase α enhances cell surface expression of neural adhesion molecule NB-3.The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells.Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsRecent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.Targeting tyrosine kinases and autophagy in prostate cancer.FOXA1 inhibits prostate cancer neuroendocrine differentiation.Role of protein phosphatases in genitourinary cancers.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism.Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer.p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer.Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer
P2860
Q21129293-4767216D-06DE-4177-AE18-224C4EB4A50AQ24630639-F07060A5-77A5-4048-93A5-CEF8EB3D2425Q24657547-EB5C89BC-CBC8-4EAD-9478-E47072063F2CQ26859201-CD75F060-DBB2-48F6-9FCD-A3BAB20406AEQ26863333-B6549718-D992-42DD-8CF0-29C79FB5C5C0Q30432236-16B13699-0433-4149-9A4B-8FD0B8BAC9D0Q30490157-A3507C37-9D9F-4E9E-B567-FBB7A393559FQ30536922-4B7C3E2A-8F29-4E54-AEA0-58E0F3861B3FQ30940949-06F68096-4350-42B5-91AC-1728302099E5Q35100846-8BDDA63A-5FA1-45CE-8BA4-9E0392B55DC7Q35110951-4E9BE43D-361F-4592-A5A4-5F58B5395DC1Q35292006-03C6C83F-397F-467A-937A-F116C423E823Q35380936-92697ACE-753C-4F0A-96F6-27F466D794BFQ36272854-2153199B-9796-40F0-ABE4-C9160E7DF4BBQ37564369-556C8CF0-C510-4A37-9C15-ACC059462CF6Q37847052-2F3B6EEE-7C5D-42C6-983F-53F4509E7976Q38893882-70CFF91E-19A6-4E35-9599-F637D7E7E4BBQ38941676-63286A3E-3A9C-4A52-9AE7-7B2F18BAD9DAQ39016544-4DD9AF27-B66D-4CBF-AB69-C3BD41E6A46DQ40262420-CD758104-6627-4705-A812-8E7E4E4EF29DQ40513840-D04E2196-593F-49EB-92E3-FBCB108B8062Q41764330-0A2BB129-3A78-44BF-80FE-3C8BCDC70CACQ43197266-C743FF04-A2F5-40ED-89AD-21EB8CAE0D2DQ43623151-91C53D65-9987-4FB6-91F8-5865B72F7C13Q47670505-35DFB240-2651-46DC-855C-7CF8AAE75A89Q58327426-1F90DFF7-5DE8-4864-8570-DB7BA947CE20
P2860
Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Receptor protein tyrosine phos ...... P human prostate cancer cells.
@en
Receptor protein tyrosine phos ...... P human prostate cancer cells.
@nl
type
label
Receptor protein tyrosine phos ...... P human prostate cancer cells.
@en
Receptor protein tyrosine phos ...... P human prostate cancer cells.
@nl
prefLabel
Receptor protein tyrosine phos ...... P human prostate cancer cells.
@en
Receptor protein tyrosine phos ...... P human prostate cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Receptor protein tyrosine phos ...... P human prostate cancer cells.
@en
P2093
Dmitry Kondrikov
Fen-Fen Lin
Joel Hansen
Ming-Fong Lin
Ta-Chun Yuan
Xiu-Qing Zhang
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206764
P407
P577
2003-10-01T00:00:00Z